Mental health is among the most common reasons people use cannabis and among the areas where the evidence is least supportive. That combination produces a lot of confident advice that the research does not back.
The most useful thing to understand is not any single condition. It is the loop that daily use creates.
The Withdrawal Trap
Cannabis withdrawal is real and was formally recognised as a diagnosis in DSM-5. Its core symptoms are anxiety, irritability, low mood, restlessness, sleep disturbance and vivid dreams.
Read that list again and notice that it is largely a description of the symptoms people use cannabis to treat.
For someone using daily, this creates a self-confirming pattern. Cannabis relieves the withdrawal that develops between doses, which feels like relief of the underlying condition. Stopping produces symptoms that feel like the condition returning, which reads as proof cannabis was necessary. Withdrawal peaks in the first week and mostly settles over two to four weeks, so the misleading period is exactly the period most people use to judge.
None of that means the original problem is imaginary. It means daily use makes it impossible to tell what cannabis is doing without a supervised break.
Depression
The evidence does not support cannabis as a treatment for depression, and some points toward harm.
Longitudinal studies have generally found cannabis use, particularly heavy or early-onset use, associated with higher rates of depression and worse depression outcomes over time. Causation is contested, since depression plausibly drives use.
Two mechanisms argue against long-term benefit. Cannabis acutely alters mood but repeated CB1 agonist exposure downregulates receptors, and withdrawal produces dysphoria. And amotivation associated with heavy use overlaps with the behavioural withdrawal and inactivity that maintain depression.
For depression, treatments with actual evidence are psychotherapy and antidepressants, and behavioural activation specifically works against the inactivity heavy cannabis use tends to encourage.
Anxiety
The most important fact is that THC has a biphasic dose response. Low doses reduce anxiety and higher doses increase it, and the crossover sits well below what many high-potency products deliver.
CBD has a more favourable profile, with studies of single doses in the hundreds of milligrams reporting reduced anxiety in public-speaking tests. The 2017 National Academies review found limited evidence that CBD improves anxiety symptoms in social anxiety disorder, and also treated the association between cannabis use and developing social anxiety disorder as reasonably supported.
So the picture is genuinely two-sided: plausible acute benefit at low doses or with CBD, and elevated risk with heavy high-THC use.
Bipolar Disorder
This is where caution should be strongest. Cannabis use in bipolar disorder is associated with earlier onset, more frequent episodes, more manic episodes, poorer treatment adherence and increased suicide risk in observational research.
THC can precipitate or worsen manic symptoms. For someone with bipolar disorder, cannabis is among the more clearly unfavourable substances, and this is not a case where low-dose caution makes it reasonable.
Psychosis and Schizophrenia
The association between cannabis use and psychotic disorders is one of the better-supported findings in the cannabis literature, and the 2017 National Academies review treated it as such. Risk scales with higher potency, earlier first use and heavier use.
What remains contested is direction and mechanism, with candidate explanations including precipitation in genetically susceptible people, self-medication of early symptoms, and shared vulnerability. These are not mutually exclusive.
For anyone with a personal or family history of psychosis or schizophrenia, avoidance is the sensible default.
ADHD
Cannabis is frequently used by people with ADHD and there is no good evidence it treats it. Some report subjective improvement in restlessness, and cannabis impairs working memory and attention, which are the domains ADHD already affects. Stimulant and non-stimulant medications have substantial evidence.
Stress
Acute stress relief is real and reflected in the dose curve above. Chronic heavy use complicates it: research has reported blunted cortisol responses to stress in regular users, which can be read as reduced reactivity or as a dysregulated stress response depending on interpretation.
The practical issue is that using a substance as the primary coping mechanism displaces skills that work without tolerance, including exercise, sleep regularity, social contact and therapy.
A Defensible Position
Bottom Line
Cannabis has a plausible acute anxiolytic effect at low doses and a poor record as a mental health treatment over time. It is associated with worse outcomes in depression, clearly unfavourable in bipolar disorder, and linked to psychosis risk that scales with potency and early use. Withdrawal mimics the symptoms people are treating, which is why daily use feels indispensable and is the hardest pattern to evaluate from inside.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making any health-related decisions.